BlackRock Institutional Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$40.5M	Buy	912,651 +58,137	+7%	+$2.05M	0.01%	1475
2016 Q3	$30.8M	Buy	854,514 +31,478	+4%	+$675K	﹤0.01%	1593
2016 Q2	$11.3M	Sell	823,036 -2,049	-0.2%	-$30K	﹤0.01%	2215
2016 Q1	$15.8M	Buy	825,085 +54,476	+7%	+$1.15M	﹤0.01%	1966
2015 Q4	$27M	Buy	770,609 +14,029	+2%	+$905K	﹤0.01%	1643
2015 Q3	$69.6M	Buy	756,580 +65,779	+10%	+$5.69M	0.01%	1040
2015 Q2	$60.7M	Sell	690,801 -28,821	-4%	-$2.47M	0.01%	1193
2015 Q1	$53.4M	Buy	719,622 +3,902	+0.5%	+$276K	0.01%	1278
2014 Q4	$40.1M	Sell	715,720 -30,796	-4%	-$1.62M	0.01%	1442
2014 Q3	$33.9M	Sell	746,516 -18,217	-2%	-$761K	0.01%	1528
2014 Q2	$31.7M	Sell	764,733 -179,237	-19%	-$9.23M	0.01%	1637
2014 Q1	$65.4M	Buy	943,970 +300,508	+47%	+$22.1M	0.01%	1118
2013 Q4	$38.8M	Buy	643,462 +221,458	+52%	+$12M	0.01%	1457
2013 Q3	$25.7M	Buy	422,004 +155,870	+59%	+$11.1M	0.01%	1673
2013 Q2	$17.8M	Buy	+266,134	New	+$12M	﹤0.01%	1888